As Marcelo Giugale published in the Financial Times, Latin America, on the whole,
has not excelled at innovation - doing the same things in a new and better way
or at doing new things. It has been slow to acquire, adopt and adapt
technologies by this time available in other places[1]. Although extracorporeal membrane oxygenation
(ECMO) is not a new technology, its use in Latin America is not widespread as
needed. Furthermore, we still have a number centers doing ECMO, not reporting
their cases, lacking a structured training program and not registered with the
extracorporeal life support organization (ELSO). With this scenario, and
accepting that ECMO is the first step in any circulatory support program, it is
difficult to anticipate the incorporation of new and more complex devices as the
technologically advanced world is currently doing. However, the good news is
that with the support of experts from USA, Europe and Canada the results in
Latin America ELSO'S centers are improving by following its guidelines for
training, and using a standard educational process. There is no doubt that we
can learn a great deal from the high velocity organizations - the rabbits - whom
everyone chases but never catches, that manage to stay ahead because of their
endurance, responsiveness, and their velocity in self-correction[2].